742
Views
14
CrossRef citations to date
0
Altmetric
Review Articles

Tramadol and the occurrence of seizures: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 710-723 | Received 09 May 2019, Accepted 15 Nov 2019, Published online: 08 Jan 2020

References

  • Abadie D, Durrieu G, Roussin A, Montastruc JL. 2013. Serious adverse drug reactions with tramadol: a 2010–2011 pharmacovigilance survey in France. Therapie. 68(2):77–84.
  • Abbasi B, Hafezimoghadam P, Nejad NA, Sarvari M, Ramim T. 2015. Assessment of time interval between tramadol intake and seizure and second drug-induced attack. Tehran Univ Med J. 73(8):592–599.
  • Adree H, Fouad H, Waleed E, Sherief M. 2018. Incidence and factors influencing acute tramadol toxicity-inducing seizures in damietta governorate. J Forens Med Clin Toxicol. 26(2):155–167.
  • Ahmadi H, Hosseini J, Rezaei M. 2011. Epidemiology of tramadol overdose in Imam Khomeini hospital, Kermanshah, Iran (2008). Behbood. 15(1):72–77.
  • Ahmadimanesh M, Shadnia S, Rouini MR, Sheikholeslami B, Ahsani Nasab S, Ghazi-Khansari M. 2018. Correlation between plasma concentrations of tramadol and its metabolites and the incidence of seizure in tramadol-intoxicated patients. Drug Metab Pers Ther. 33(2):75–83.
  • Alinejad S, Zamani N, Abdollahi M, Mehrpour O. 2017. A narrative review of acute adult poisoning in Iran. Iran J Med Sci. 42(4):327
  • Asadi P, Kasmaei VM, Ziabari SZ, Zohrevandi B, Manesh AM. 2015. Prevalence of tramadol consumption in first seizure patients; a one-year cross-sectional study. Emergency. 3(4):159.
  • Berecki‐Gisolf J, Hassani-Mahmooei B, Clapperton A, McClure R. 2017. Prescription opioid dispensing and prescription opioid poisoning: population data from Victoria, Australia 2006 to 2013. Aust NZ J Pub Health. 41(1):85–91.
  • Boostani R, Derakhshan S. 2012. Tramadol induced seizure: a 3-year study. Caspian J Intern Med. 3(3):484
  • Boushehri B, Dalir M, Hasanlouee V. 2014. Evaluation of clinical findings and acute compilications in patient's admitted to Urmia Taleghani Hospital with tramadol intoxication at 2012-2013. Iran J Anaesthesiol Crit Care. 36(1):41–49.
  • Bradford LD. 2002. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 3(2):229–243.
  • da Silva O, Alexandrou D, Knoppert D, Young GB. 1999. Seizure and electroencephalographic changes in the newborn period induced by opiates and corrected by naloxone infusion. J Perinatol. 19(2):120.
  • Eizadi-Mood N, Ozcan D, Sabzghabaee AM, Mirmoghtadaee P, Hedaiaty M. 2014. Does naloxone prevent seizure in tramadol intoxicated patients? Int J Prev Med. 5(3):302
  • El-Hadidy MA, El-Gilany A-H. 2016. Seizure associated with tramadol dependence: a cross-sectional study. Arab J Psychiatry. 27(2):160–169.
  • Emamhadi M, Sanaei-Zadeh H, Nikniya M, Zamani N, Dart RC. 2012. Electrocardiographic manifestations of tramadol toxicity with special reference to their ability for prediction of seizures. Am J Emerg Med. 30(8):1481–1485.
  • Enaba D, Shalaby NM, El-Baz H, Zahra A, Kishk NA, Moselhy HF. 2015. The influence of A118G single nucleotide polymorphism of human mu opioid receptor gene and the MDR1 gene in Egyptian patients with tramadol-induced seizure. Addict Disord Their Treatment. 14(2):105–112.
  • Farajidana H, Hassanian-Moghaddam H, Zamani N, Sanaei-Zadeh H. 2012. Tramadol-induced seizures and trauma. Eur Rev Med Pharmacol Sci. 16(Suppl 1):34–37.
  • Farzaneh E, Mostafazadeh B, Mehrpour O. 2012a. Seizurogenic effects of low-dose naloxone in tramadol overdose. Iran J Pharmacol Therapeut. 11(1):6–0.
  • Farzaneh E, Samadzadeh M, Shahbazzadegan B, Sayadrezai I, Mostafazadeh B, Sarbandi Farahani A, Habibzadeh S. 2012b. Comparing the frequency of seizure in patients intoxicated with tramadol treated with or without naloxone. J Isfahan Med School. 30(197):1–7.
  • Gardner JS, Blough D, Drinkard CR, Shatin D, Anderson G, Graham D, Alderfer R. 2000. Tramadol and seizures: a surveillance study in a managed care population. Pharmacother: J Hum Pharmacol Drug Therapy. 20(12):1423–1431.
  • Gasse C, Derby L, Vasilakis-Scaramozza C, Jick H. 2000. Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy. 20(6):629–634.
  • Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S. 2007. New guideline for tramadol usage following adverse drug reactions reported to the Iranian pharmacovigilance center. Pharmacoepidem Drug Safe. 16(2):229–237.
  • Gilbert P, Martin W. 1975. Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice. J Pharmacol Exp Ther. 192(3):538–541.
  • Goodarzi F, Mehrpour O, Eizadi-Mood N. 2011. A study to evaluate factors associated with seizure in tramadol poisoning in Iran. Ind J Forensic Med Toxicol. 5(2):66–69.
  • Hara K, Minami K, Sata T. 2005. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth Analg. 100(5):1400–1405.
  • Hassanian-Moghaddam H, Farajidana H, Sarjami S, Owliaey H. 2013. Tramadol-induced apnea. Am J Emerg Med. 31(1):26–31.
  • Hussien R, Elguindy M. 2017. Assessment of the role of naloxone in the prognosis of tramadol intoxicated patients. J Clin Toxicol. 7(366):21610495.
  • Jick H, Derby LE, Vasilakis C, Fife D. 1998. The risk of seizures associated with tramadol. Pharmacother: J Hum Pharmacol Drug Therapy. 18(3):607–611.
  • Jovanović-Čupić V, Martinović Ž, Nešić N. 2006. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol. 44(2):143–146.
  • Khan TH, Sukhera SA, Amjad M, Saleemi S. 2009. Safety of tramadol as a pre-induction agent. Anaesth Pain Intens Care. 13(2):57–60.
  • Lagard C, Malissin I, Indja W, Risède P, Chevillard L, Mégarbane B. 2018. Is naloxone the best antidote to reverse tramadol-induced neuro-respiratory toxicity in overdose? An experimental investigation in the rat. Clin Toxicol. 56(8):737–743.
  • Layegh P, Pour Z, Jarahi L, Dadpour B. 2017. Brain MRI findings in tramadol poisoning. Asia Pacific J Med Toxicol. 6(4):102–107.
  • Marquardt KA, Alsop JA, Albertson TE. 2005. Tramadol exposures reported to statewide poison control system. Ann Pharmacother. 39(6):1039–1044.
  • Mehrpour O, Taghaddosi-Nejad F, Seghatoleslami A, Chalaki N, Afshari R. 2010. Tramadol poisoning induced seizure. Toxicol Lett. 196(196):S79–S80.
  • Mohammadpour A, Ashkezari MD, Farahmand B, Shokrzadeh M. 2018. Demographic characteristics and functional performance of the kidneys and hearts of patients with acute tramadol toxicity. Drug Res (Stuttg). 69(04):207–210.
  • Mood NE, Sabzghabaee AM, Safdari A, Yaraghi A. 2011. Clinical signs, hospitalization duration and outcome of tramadol intoxication. J Isfahan Med School. 28(117):1–7.
  • Moulis F, Rousseau V, Abadie D, Masmoudi K, Micallef J, Vigier C, Pierre S, Dautriche A, Montastruc F, Montastruc JL. 2017. Serious adverse drug reactions with tramadol reported to the French pharmacovigilance database between 2011 and 2015. Therapie. 72(6):615–624.
  • Murray BP, Carpenter JE, Dunkley CA, Moran TP, Alfaifi M, Alsukaiti WS, Kazzi Z. 2019. Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone. Clin Toxicol. 57(8):692–696.
  • Nasouhi S, Talaie H, Pajoumand A, Aghapour S, Rahimi M, Khorasani AG, Mashayekhian M, Aghabiklooei A, Razi P, Mahdavinejad A. 2015. Hypo and hyperglycemia among tramadol overdose patients in Loghman Hakim Hospital, Tehran, Iran. Pak J Pharm Sci. 28(6):1959–1963.
  • Nasr MA, Mahmoud SF, Mohammed MA, El-Samie H. 2018. A study of clinical and laboratory picture of acute tramadol toxicity in damietta governorate. J Forens Med Clin Toxicol. 26(2):143–153.
  • Chhabra N, Pallasch EM, Wahl MS, Bryant SM. 2017. Tramadol and naloxone: seizure association and/or therapeutic effect. Abstracts from the 2017 American College of Medical Toxicology (ACMT) Annual Scientific Meeting. J Med Toxicol. 13:3–46.
  • Okazi A, Taghaddosinejad F, Mazrouei N, Forouzesh M, Barzegar A, Fallah F. 2018. Occurrence and recurrence of seizures and related factors in patients with tramadol ingestion. Int J Med Toxicol Forensic Med. 8(3):101–108.
  • Petramfar P, Haghighi AB. 2010. Tramadol induced seizure: report of 106 patients. Iranian Red Crescent Med J. 12(1):49.
  • Potschka H, Friderichs E, Loscher W. 2000. Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy. Br J Pharmacol. 131(2):203–212.
  • Rahimi HR, Soltaninejad K, Shadnia S. 2014. Acute tramadol poisoning and its clinical and laboratory findings. J Res Med Sci. 19(9):855.
  • Rehni AK, Singh I, Kumar M. 2008. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent gamma-aminobutyric acid inhibitory pathway. Basic Clin Pharmacol Toxicol. 103(3):262–266.
  • Rezk MM. 2013. A Study of Seizure Frequency among Tramadol Abusers Attending Minia Psychiatric Hospital Doctoral dissertation, Minia University.
  • Rezk NN, Khater AS, Sarhan NM. 2012. Tramadol induced seizures; in relation to patient criteria and tramadol dose. Egypt J Forens Sci Appl Toxicol. 220(1246):1–9.
  • Rizk MM, Kamal AM, Bakheet MA, Abdelfadeel NA, Hassan EM, Khafagi AT. 2016. Frequency and factors associated with occurrence of seizures in patients with tramadol abuse: an upper Egyptian experience. Addict Disord Treat. 15(1):42–48.
  • Ryan NM, Isbister GK. 2015. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol. 53(6):545–550.
  • Saidi H, Ghadiri M, Abbasi S, Ahmadi SF. 2010. Efficacy and safety of naloxone in the management of postseizure complaints of tramadol intoxicated patients: a self-controlled study. Emerg Med J. 27(12):928–930.
  • Sansone RA, Sansone LA. 2009. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 6(4):17–21.
  • Scells H, Zuccon G, Koopman B, Deacon A, Azzopardi L, Geva S. 2017. Integrating the framing of clinical questions via PICO into the retrieval of medical literature for systematic reviews. In Proceedings of the 2017 ACM on Conference on Information and Knowledge Management; Nov 6–10; Singapore. p. 2291–2294
  • Shadnia S, Brent J, Mousavi‐Fatemi K, Hafezi P, Soltaninejad K. 2012. Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients. Basic Clin Pharmacol Toxicol. 111(2):133–136.
  • Shadnia S, Soltaninejad K, Heydari K, Sasanian G, Abdollahi M. 2008. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol. 27(3):201–205.
  • Shipton EE, Shipton AJ, Williman JA, Shipton EA. 2017. Deaths from opioid overdosing: implications of coroners’ inquest reports 2008–2012 and annual rise in opioid prescription rates: a population-based cohort study. Pain Ther. 6(2):203–215.
  • Shokrzadeh M, Hajimohammadi A, Delaram A, Shayeste Y. 2017. Characteristics of patients hospitalized with tramadol intoxication in Gorgan, Iran, 2008–2015. J Mazandaran Univ Med Sci. 26(146):185–190.
  • Soleymani F, Shalviri G, Abdollahi M. 2011. Pattem of use and adverse drug reactions of tramadol; A review of 336, 610, 664 insured prescriptions during 5 years. Int J Pharmacol. 7(7):757–760.
  • Spiller HA, Gorman SE, Villalobos D, Benson BE, Ruskosky DR, Stancavage MM, Anderson DL. 1997. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 35(4):361–364.
  • Stassinos GL, Gonzales L, Klein-Schwartz W. 2019. Characterizing the toxicity and dose-effect profile of tramadol ingestions in children. Pediatr Emerg Care. 35(2):117–120.
  • Taghaddosinejad F, Mehrpour O, Afshari R, Seghatoleslami A, Abdollahi M, Dart RC. 2011. Factors related to seizure in tramadol poisoning and its blood concentration. J Med Toxicol. 7(3):183.
  • Talaie H, Panahandeh R, Fayaznouri MR, Asadi Z, Abdollahi M. 2009. Dose-independent occurrence of seizure with tramadol. J Med Toxicol. 5(2):63–67.
  • Taromsari MR, Badsar AR, Bahrami F, Jahanseir K, Fallah Karkan M. 2012. Clinical and laboratory findings in patients with tramadol intoxication referred to razi hospital during 2005–06. Iran J Toxicol. 6(16):605–609.
  • Tsutaoka BT, Ho RY, Fung SM, Kearney TE. 2015. comparative toxicity of tapentadol and tramadol utilizing data reported to the national poison data system. Ann Pharmacother. 49(12):1311–1316.
  • Vadivelu N, Chang D, Helander EM, Bordelon GJ, Kai A, Kaye AD, Hsu D, Bang D, Julka I. 2017. Ketorolac, oxymorphone, tapentadol, and tramadol: a comprehensive review. Anesthesiol Clin. 35(2):e1–e20.
  • Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. 2009. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [accessed 2009 Oct 19] http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • Yang T, Tao J, Wu Y. 2006. Epileptiform seizures induced by intravenous injection of tramadol during epidural anesthesia chongqing Med J. 7:581–582.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.